← SynDRA
ESZOPICLONE
SynDRA canonical compound SYN0008487 — structure-anchored drug synonym record
| Approval status | Approved · Rx/OTC |
| Primary target(s) | GABRQ |
| Mechanism of action | GABA receptor agonist |
All known targets
- GABRA1
- GABRA3
- GABRA4
- GABRA5
- GABRB2
- GABRA2
- GABRG3
- GABRG2
- GABRG1
- GABRQ
- GABRP
- GABRB3
Mechanisms of action (all sources)
- GABA receptor agonist
- TSPO AGONIST
- GABRA2 POSITIVE ALLOSTERIC MODULATOR
- GABRA4 POSITIVE ALLOSTERIC MODULATOR
- GABRA1 POSITIVE ALLOSTERIC MODULATOR
- GABRG2 POSITIVE ALLOSTERIC MODULATOR
- GABRB2 POSITIVE ALLOSTERIC MODULATOR
- GABRG3 POSITIVE ALLOSTERIC MODULATOR
- GABRA3 POSITIVE ALLOSTERIC MODULATOR
- GABRA5 POSITIVE ALLOSTERIC MODULATOR
Drug classes
- Central Nervous System Agents
- Central Nervous System Depressants
- Hypnotics and Sedatives
ATC classes
- N05C · HYPNOTICS AND SEDATIVES
Cross-references
Synonyms
- esopiclone
- lunesta
- Eszopiclona
- Zopiclone s-form
- Estorra
- Eszopiclon
- (S)-ZOPICLONE
- GSK-1755165
- Lunesta
- Eszopiclone civ
- Esopiclone
- Lunivia
- Estorra (TN)
- Eszopiclone [USAN:INN]
- KS-1055
- SEP-0227018
- SEP-0227108
- SEP-190
- SEP-225441
- Eszopiclone (JAN/USAN/INN)
- [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
- (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
- (5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
- (5S)-6-(5-chloropyridin-2-yl)-7-oxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
- (5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
- (S)-Zopiclone
- (plus)-Zopiclone
- 1-Piperazinecarboxylic acid, 4-methyl-, (5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester
- eszopiclone civ (usp-rs)
- UZX80K71OE
- Zopiclone s-
- eszopiclone (usp monograph)
- (+)-Zopiclone
- eszopiclona
- CHEBI:53760
- DTXCID6026086
- eszopiclonum
- RefChem:56355
Reported adverse events
- Anxiety
- Depression
- Dizziness
- Dyspepsia
- Hallucination
- Headache
- Nausea
- Nervousness
- Pruritus
- Rash
- Somnolence
- Vomiting
Look up ESZOPICLONE in the interactive SynDRA portal →